A Longitudinal Prospective Observational Study of the Characteristics Treatment Patterns and Health Outcomes of Individuals with Severe Asthma in the United States

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subjects diagnosed with severe asthma for at least 12 months
    2. Subjects receiving care from specialist physicians (eg, pulmonologists and/or allergists) at the Investigator’s or sub-investigator’s site
    3. Subjects who are 18 years old or older
    4. Subjects who meet at least one of the following 3 criteria:
      • Have uncontrolled on asthma treatment consistent with GINA (Global Initiative for Asthma) or frequent severe exacerbations or airflow limitations OR
      • Current use of a Food and Drug Administration (FDA)-approved monoclonal antibody agent for treatment of severe asthma
      • Use of systemic corticosteroids or other systemic immunosuppressants (any dose level) for approximately 50% or more of the prior 12 months for treatment of severe asthma

You may not be eligible for this study if the following are true:

    1. Subjects who are not willing and able to sign written informed consent.
    2. Subjects who are not fluent in English or Spanish
    3. Subjects with anability to complete study follow-up or web-based PROs
    4. Subjects who received an investigational therapy for asthma, allergy, atopic disease, or eosinophilic disease as part of a clinical trial during the 6 months prior to enrollment.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.